Legal & General Global Health & Pharmaceuticals Index Trust
Unit Trust (UK UCITS compliant)
Legal & General Global Health & Pharmaceuticals Index Trust
R-Class GBP Accumulation
ISINGB0001955532
Price
ISINGB0001955532
Price
Fund aim
The objective of the Fund is to track performance of the FTSE World Index - Health Care, the "Benchmark Index" on a net total return basis before fees and expenses are applied. Fund performance may differ from the Benchmark Index due to the deduction of fees and expenses and the impact of any tracking error factors.
Fund snapshot
- What does it invest in? Invests in the shares of global companies engaged in healthcare, pharmaceutical and biotechnology activities, as represented by the Index.
- How does it invest? Passively managed, aiming to replicate the performance of the Index.
Fund facts
Fund size | £1,059.3m |
Base currency | GBP |
Fund launch date | 1 Nov 2000 |
Domicile | UK |
Share class launch | 1 Nov 2000 |
Historical yield | 0.9% |
Benchmark
FTSE World - Health Care Index
Costs
Initial charge | 0.00% |
Ongoing charges figure | 0.69% |
Dilution adjustment | 0.16% - round trip |
Performance
Portfolio breakdown
As at 31 Jan 2024
Top 10 holdings | 43.2% |
---|---|
Rest of portfolio | 56.8% |
No. of holdings in fund | 195 |
---|---|
No. of holdings in index | 194 |
Top 10 holdings (%)
Eli Lilly & Co | 7.5 |
Unitedhealth Group | 6.4 |
Johnson & Johnson | 5.2 |
Novo Nordisk B | 4.9 |
Merck & Co | 4.2 |
Abbvie | 3.9 |
Novartis | 2.9 |
Thermo Fisher Scientific | 2.9 |
Roche Holding | 2.8 |
Abbott Laboratories | 2.7 |
Sector (%)
Health Care | 100.0 |
Other | 0.0 |
Top 10 holdings | 43.2% |
---|---|
Rest of portfolio | 56.8% |
No. of holdings in fund | 195 |
---|---|
No. of holdings in index | 194 |
Top 10 holdings (%)
Eli Lilly & Co | 7.5 |
Unitedhealth Group | 6.4 |
Johnson & Johnson | 5.2 |
Novo Nordisk B | 4.9 |
Merck & Co | 4.2 |
Abbvie | 3.9 |
Novartis | 2.9 |
Thermo Fisher Scientific | 2.9 |
Roche Holding | 2.8 |
Abbott Laboratories | 2.7 |
Sector (%)
Health Care | 100.0 |
Other | 0.0 |
Market capitalisation (%)
Large | 86.5 |
Mid | 13.5 |
Country (%)
United States | 69.3 |
Switzerland | 7.5 |
Denmark | 5.6 |
Japan | 4.5 |
United Kingdom | 4.4 |
France | 2.6 |
Australia | 1.7 |
Germany | 1.5 |
Korea | 0.7 |
Other | 2.1 |
All data source LGIM unless otherwise stated. Totals may not sum due to rounding. In order to minimise transaction costs, the Fund will not always own all the assets that constitute the index and on occasion it will own assets that are not in the index. The figures shown for market capitalisation (the total share value of a company) may not be comparable between funds as they can be measured and classed in different ways.
Fund managers
LGIM Index Fund Management Team
The Index Fund Management team comprises 25 fund managers, supported by two analysts. Management oversight is provided by the Global Head of Index Funds. The team has average industry experience of 15 years, of which seven years has been at LGIM, and is focused on achieving the equally important objectives of close tracking and maximising returns.
Literature
Document type
Prices
Pricing information
Price basis | Single swing |
Price time | 15:00 UK time |
Currency | GBP |
Download full price history
Codes and dealing
Codes
ISIN | GB0001955532 |
SEDOL | 0195553 |
Bloomberg | LEGGHPA |
MEX | LGHPIA |
Dealing information
Valuation frequency | Daily, 3pm (UK time) |
Dealing frequency | Daily |
Settlement period | T+4 |
Country registration
This share class is registered for sale in the following countries: